medlogicai.org

Clinical intelligence. Better decisions.

Decision-Making Algorithm in Otorhinolaryngology & Head and Neck Surgery

Hypopharyngeal Carcinoma

Late dysphagia or a neck node to the worst-prognosis head-and-neck cancer — mapping, larynx preservation, and the bilateral neck

Step 1

Step 1 of 14

Presentation & Airway Assessment

Late dysphagia · odynophagia · referred otalgia · hoarseness · neck mass + airway triage

Hypopharyngeal carcinoma is the great late presenter. Arising in the pyriform sinus, postcricoid region, or posterior pharyngeal wall, it grows silently in a capacious space and declares itself only when advanced. The typical features are progressive dysphagia and odynophagia, referred otalgia (via the vagus), globus, a neck mass (frequently the first sign, often bilateral), weight loss, haemoptysis, and a hoarse voice or aspiration when the larynx or recurrent laryngeal nerve is involved.

Before the elective work-up, the airway is assessed — a bulky hypopharyngeal tumour with laryngeal involvement can obstruct or cause aspiration, and stridor, respiratory distress, or progressive obstruction warrants a planned, controlled airway (awake fibreoptic intubation or controlled tracheostomy). The combination of dysphagia, otalgia, and a neck node in a tobacco-and-alcohol user is the pattern that must trigger urgent pharyngeal endoscopy rather than a trial of reflux therapy.

  • Symptoms — progressive dysphagia, odynophagia, referred otalgia, globus
  • Neck mass (often first sign, frequently bilateral); weight loss, haemoptysis
  • Hoarseness / aspiration when larynx or recurrent laryngeal nerve involved
  • Airway — stridor/obstruction → planned controlled airway (awake fibreoptic / tracheostomy)

Key statistics

  • Hypopharyngeal cancer prognosis

    worst-prognosis H&N SCC

    Hypopharyngeal carcinoma carries the poorest survival among head-and-neck squamous cancers — late presentation, submucosal/skip spread, early bilateral and distant metastasis, and a high second-primary rate all contribute.

    PMID 30943471

★ High-yield pearls (chapter-wide)

  • Hypopharyngeal cancer presents late and silently — persistent dysphagia, odynophagia, referred otalgia, a hoarse voice, or a neck node in a smoker-drinker is hypopharyngeal carcinoma until the pharynx is scoped.
  • It carries the worst prognosis of the head-and-neck squamous cancers — extensive submucosal spread, skip lesions, early bilateral nodal and distant metastasis, and a high second-primary rate all conspire against cure.
  • Map the true extent at panendoscopy, not just the visible tumour — submucosal spread and skip lesions routinely extend well beyond the mucosal edge and determine resection margins and reconstruction.
  • The retropharyngeal (Rouvière) and bilateral level II–IV nodes are at high risk and must be imaged and treated — hypopharyngeal cancer metastasises early and to both sides.
  • Prevertebral-fascia fixation and carotid encasement render disease unresectable — assess the prevertebral plane and the carotid on MRI before committing to surgery.
  • Larynx preservation with induction chemotherapy followed by radiotherapy gives survival equivalent to pharyngolaryngectomy in selected patients — EORTC 24891 established this for hypopharyngeal cancer.
  • Postcricoid carcinoma in an iron-deficient woman is the Plummer-Vinson (Paterson-Brown-Kelly) association — one of the few non-tobacco hypopharyngeal cancers.
  • Surgery for advanced disease usually means total laryngopharyngectomy with free-flap (ALT/radial-forearm/jejunal) or gastric-pull-up reconstruction — plan the conduit and the swallow before operating.
  • Positive margins or extranodal extension on final pathology mandate concurrent cisplatin chemoradiotherapy, not radiotherapy alone.
  • Swallowing is the dominant functional outcome — stricture, aspiration, and feeding-tube dependence are common after any modality, so build swallow rehabilitation and surveillance into the plan from the start.

Evidence base

3 sources
  1. MOD

    Mahalingam S & Spielmann P · Adv Otorhinolaryngol · 2019ReviewPMID 30943471

    Review of quality-of-life and functional (especially swallowing) outcomes after hypopharyngeal-cancer treatment.

  2. MOD

    Kwon DI & Miles BA · Head Neck · 2019Guideline reviewPMID 30570183

    Guideline-anchored review of hypopharyngeal-carcinoma workup, staging, and stage-directed management.

  3. HIGH

    Steuer CE, El-Deiry M, Parks JR · CA Cancer J Clin · 2017ReviewPMID 27898173

    Review of laryngeal/hypopharyngeal cancer principles — epidemiology, staging, and management.

Decision tree

The triage screen is the first gate. Classification routes the stable patient to one of the aetiology-keyed pathways below. Cross-cut cards capture the chapter's must-not-miss rules.

Step 1 — TriageRed-flag screenNo red flagPathway classification?Early (A)T1–T2 N0 (uncommon) — radiotherapy or transoral surgery +bilateral neckTransoral surgery (B)Selected lateral pyriform/posterior wall — TLM/TORS;apex/postcricoid defeat accessLarynx preservation (C)Advanced/unresectable — induction → CRT (responders) /salvage; EORTC 24891Laryngopharyngectomy (D)Advanced non-candidate — total laryngopharyngectomy +reconstruction + bilateral neckReconstruction (E)Free flap (RFFF/ALT/jejunal) by defect; gastric pull-up forcervical oesophagusNeck (F)Both necks (II–IV) + retropharyngeal nodes; level VI ifoesophageal extensionAdjuvant (G)High-risk path → RT; positive margins / extranodal extension →cisplatin CRTSalvage (H)Resectable recurrence — salvage laryngopharyngectomy;flap-reinforced closureRecurrent/metastatic (I)PD-L1-guided pembrolizumab; early palliative + nutritionalcareRehab / survivorship (J)Swallow rehab + dilatation; TEP voice; second-primarysurveillancePathways:A EarlyB Transoral surgeryC Larynx preservationD LaryngopharyngectomyE ReconstructionF NeckG AdjuvantH SalvageI Recurrent/metastaticJ Rehab / survivorship
Step 1

Disclaimer

For educational purposes only. Not for clinical use. This platform is an instructional resource intended to support learning about clinical decision-making and the interpretation of investigations. Clinicians remain completely responsible for the interpretation of findings, the formulation of a differential diagnosis, and any clinical decision. Nothing in this application replaces individualized assessment, hands-on training, expert consultation, or established practice guidelines.

Not for profit effort by

Dr. Prahlada N.B

  • MBBS (JJMMC), MS (PGIMER, Chandigarh)
  • MBA in Hospital & Healthcare Management (BITS, Pilani)
  • Postgraduate Certificate in Technology Leadership and Innovation (MIT, USA)
  • Executive Programme in Strategic Management (IIM, Lucknow)
  • Senior Management Programme in Healthcare Management (IIM, Kozhikode)
  • Advanced Certificate in AI for Digital Health and Imaging Program (IISc, Bengaluru)

Supporting organisations

  • Karnataka ENT Hospital and Research Centre (R)
  • Champions Educational and Medical Society (R)
  • Amogh Foundation